Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2003

01-12-2003 | Brief Report

Mycobacterium szulgai Isolated from a Patient, a Tropical Fish and Aquarium Water

Authors: M. L. Abalain-Colloc, D. Guillerm, M. Saläun, S. Gouriou, V. Vincent, B. Picard

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2003

Login to get access

Excerpt

Mycobacterium szulgai is rare in nature and humans. To date, the organism has been isolated from a snail and a tropical fish [1] and it accounts for less than 1% of all human isolates of nontuberculous mycobacteria. When present, however, it is mostly considered as a true pathogen. Since the organism was first described in 1972 [7], sporadic cases of infection have been reported regularly. Mycobacterium szulgai infection typically causes chronic lung disease, but it may present a variety of clinical manifestations such as bursitis, keratitis, synovitis, osteomyelitis and systemic infections in immunocompromised patients [1, 2, 3, 4, 5, 6]. We report here the case of a patient with pulmonary disease due to Mycobacterium szulgai and the results of our epidemiological investigation aimed at identifying the source of the microorganism. …
Literature
1.
go back to reference Benator DA, Kan V, Gordin FM (1997) Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen. Am J Med Sci 313:346--351PubMed Benator DA, Kan V, Gordin FM (1997) Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen. Am J Med Sci 313:346--351PubMed
2.
go back to reference Fang CT, Chang SC, Luh KT, Chang YL, Hsueh PR, Hsieh WC (1999) successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol. J Infect 38:195--197PubMed Fang CT, Chang SC, Luh KT, Chang YL, Hsueh PR, Hsieh WC (1999) successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol. J Infect 38:195--197PubMed
3.
go back to reference Fruech BE, Dubuis O, Imesch P, Böhnke M, Bodmer T (2000) Mycobacterium szulgai keratis. Arch Ophthalmol 118:1123--1124PubMed Fruech BE, Dubuis O, Imesch P, Böhnke M, Bodmer T (2000) Mycobacterium szulgai keratis. Arch Ophthalmol 118:1123--1124PubMed
4.
go back to reference Horusitzky A, Puéchal X, Dumont D, Bégué T, Robineau M, Boissier MC (2000) Canal tunnel syndrome caused by Mycobacterium szulgai. J Rheumatol 27 (5):1299--1302PubMed Horusitzky A, Puéchal X, Dumont D, Bégué T, Robineau M, Boissier MC (2000) Canal tunnel syndrome caused by Mycobacterium szulgai. J Rheumatol 27 (5):1299--1302PubMed
5.
go back to reference Hurr H, Sorg T (1998) Mycobacterium szulgai osteomyelitis. J Infect 137:191--192 Hurr H, Sorg T (1998) Mycobacterium szulgai osteomyelitis. J Infect 137:191--192
6.
go back to reference Luque AE, Kaminski D, Reichman R, Hardy D (1998) Mycobacterium szulgai osteomyelitis in an AIDS patient. Scand J Infect Dis 30:88--91CrossRefPubMed Luque AE, Kaminski D, Reichman R, Hardy D (1998) Mycobacterium szulgai osteomyelitis in an AIDS patient. Scand J Infect Dis 30:88--91CrossRefPubMed
7.
go back to reference Marks J, Jenkins PA, Tsukamura M (1972) Mycobacterium szulgai. A new pathogen. Tubercle 53:210--214PubMed Marks J, Jenkins PA, Tsukamura M (1972) Mycobacterium szulgai. A new pathogen. Tubercle 53:210--214PubMed
8.
go back to reference Talenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T (1993) Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31:175--178PubMed Talenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T (1993) Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31:175--178PubMed
9.
go back to reference Tortoli E, Besozzi G, Lacchini C, Penati V, Simonetti MT, Emler S (1998) Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature. Eur Respir J 11:975--977 Tortoli E, Besozzi G, Lacchini C, Penati V, Simonetti MT, Emler S (1998) Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature. Eur Respir J 11:975--977
10.
go back to reference Wallace RJ, Zhang Y, Brown BA, Fraser V, Masurek GH, Malomey S (1993) DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol 31:2697--2701PubMed Wallace RJ, Zhang Y, Brown BA, Fraser V, Masurek GH, Malomey S (1993) DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol 31:2697--2701PubMed
Metadata
Title
Mycobacterium szulgai Isolated from a Patient, a Tropical Fish and Aquarium Water
Authors
M. L. Abalain-Colloc
D. Guillerm
M. Saläun
S. Gouriou
V. Vincent
B. Picard
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1036-x

Other articles of this Issue 12/2003

European Journal of Clinical Microbiology & Infectious Diseases 12/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.